Health Canada inspection
sanofi-aventis Canada Inc.: Health Canada inspection of Feb 20, 2026
Health Canada · GMP · rating C
Key facts
| Establishment | sanofi-aventis Canada Inc. |
|---|---|
| City | Toronto |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Feb 17, 2026 |
| End date | Feb 20, 2026 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101470 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.